Navigation Links
Flu Viruses Gaining Resistance, Study Confirms

TUESDAY, Dec. 7 (HealthDay News) -- Certain influenza virus strains are developing increasing drug resistance and greater ability to spread, a new study warns.

American and Canadian researchers confirmed that resistance to the two approved classes of antiviral drugs can occur in several ways and said this dual resistance has been on the rise over the past three years.

The team analyzed 28 seasonal H1N1 influenza viruses that were present in five countries from 2008 to 2010 and were resistant to both M2 blockers (adamantanes) and neuraminidase inhibitors (NAIs), including oseltamivir and zanamivir.

The researchers found that additional antiviral resistance can rapidly develop in a previously single-resistant influenza virus through mutation, drug response, or gene exchange with another virus.

The study also found that the proportion of tested viruses with dual resistance increased from 00.6 percent in 2007-08 to 1.5 percent in 2008-09 and 28 percent in 2009-10.

The findings are published online Dec. 7 in advance of print publication Jan. 1 in the Journal of Infectious Diseases.

"Because only two classes of antiviral agents are approved, the detection of viruses with resistance to drugs in both classes is concerning," study author Dr. Larisa Gubareva, of the U.S. Centers for Disease Control and Prevention, said in a journal news release.

"If circulation of these viruses with dual resistance becomes more widespread among any of the predominant circulating influenza A viruses, treatment options will be extremely limited," she added. "New antiviral agents and strategies for antiviral therapy are likely to be necessary in the future."

Another study in the same issue of the journal examined an outbreak of oseltamivir-resistant pandemic H1N1 influenza in a hematology unit in a British hospital. The researchers concluded "that oseltamivir may not be the frontline drug of choice in hematology patients, and zanamivir may prove to be more beneficial."

In an editorial accompanying the two studies, experts said increased monitoring and creative prevention and treatment choices will be needed as unpredictable and antiviral-resistant influenza viruses continue to appear.

With only two classes of antiviral drugs approved for use in most countries, future research should focus on the effectiveness of zanamivir and combination antiviral therapy and the development of new types of antiviral drugs, wrote Dr. Frederick G. Hayden, of the University of Virginia School of Medicine, and Dr. Menno D. de Jong, of the University of Amsterdam in the Netherlands.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about influenza.

-- Robert Preidt

SOURCE: Journal of Infectious Diseases, news release, Dec. 7, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers
2. Targeting hit-and-run cancer viruses
3. Researchers find function of proteins that can enhance the progression of viruses and cancer cells
4. To attack H1N1, other flu viruses, gold nanorods deliver potent payload
5. Mount Sinai discovers bone marrow plays critical role in enhancing immune response to viruses
6. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
7. Mild-mannered metabolic helper rushes to fight invading viruses, researchers report
8. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
9. UBC graduate student finds a start/stop switch for retroviruses
10. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
11. Gaining Weight Raises Risk of Heart Disease
Post Your Comments:
Related Image:
Flu Viruses Gaining Resistance, Study Confirms
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community ... 30 (see Table 1-1 ). More than 3.7 billion people under the age ... type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . , ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop ... not only fulfilling the needs of advisers and clients but going above and ... providing top-tier customer service. However, there's always room for improvement, which is why ...
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap and ... Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s Santa Rosa ... Sepsis conditions present in similar ways and require time-critical intervention to avoid large area ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, ... choose to buy during the Black Friday and Cyber Monday massage chair sales ... search the Internet high and low to find the best massage chair deals, they ...
(Date:11/26/2015)... ... November 26, 2015 , ... Jobs in hospital medical laboratories and in the ... healthcare staffing agency Aureus Medical Group . These fields, as well ... those searching for healthcare jobs through the company’s website, , The ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Calif. , Nov. 25, 2015  Amgen (NASDAQ: ... Biologics License Application (BLA) with the United ... for ABP 501, a biosimilar candidate to Humira ® ... adalimumab biosimilar application submitted to the FDA and represents ... Sean E. Harper , M.D., executive vice ...
(Date:11/25/2015)... WILMINGTON, N.C. , Nov. 25, 2015 /PRNewswire/ ... announces the planned investment of at least $15.8 ... in Wilmington, NC . The ... services capacity to meet the growing demands of ... Wilmington site expansion will provide up ...
(Date:11/25/2015)... , Nov. 25, 2015  Henry Schein, Inc., the ... to office-based dental, medical and animal health practitioners, will ... the Henry Schein ConnectDental® Pavilion , which brings ... of open solutions designed to help any practice or ... here for a schedule of experts appearing at ...
Breaking Medicine Technology: